Evaluation of Financial Conflicts of Interest and Quality of Evidence in Japanese Gastroenterology Clinical Practice Guidelines.

There were extensive financial COI between pharmaceutical companies and guideline authors, and more than 40% of recommendations were based on low-quality evidence. More rigorous and transparent COI policies for guideline development adhering to global standards are warranted.